Quarterly report pursuant to Section 13 or 15(d)

CONVERTIBLE DEBT - Marpai Health Convertible Notes - 2021 Convertible Notes (Details)

v3.21.2
CONVERTIBLE DEBT - Marpai Health Convertible Notes - 2021 Convertible Notes (Details)
2 Months Ended
Jul. 29, 2021
Mar. 31, 2021
USD ($)
item
Debt Instrument [Line Items]    
Term of debt 6 months  
2021 Convertible Notes    
Debt Instrument [Line Items]    
Aggregate principal amount   $ 250,000
Term of debt   2 years
Minimum gross proceeds of equity financing required for automatic conversion of notes   $ 2,000,000
Price per share determined based on maximum pre-money valuation on a fully diluted basis   $ 35,000,000
Price per share determined based on discount on lowest price per share paid by the investors in financing round   30.00%
IPO Price As Percentage Of Per Share Public Offering Price Stated In The Final Prospectus   70.00%
Number of times the note amount, plus any accrued and unpaid interest payable upon change in control | item   1.5
Interest rate   8.00%